451
Participants
Start Date
December 21, 2021
Primary Completion Date
June 14, 2023
Study Completion Date
June 14, 2023
Dotinurad
Dotinurad oral tablets.
Febuxostat
Febuxostat oral tablets.
Dotinurad Matched Placebo
Dotinurad matched placebo oral tablets.
Febuxostat Matched Placebo
Febuxostat matched placebo oral tablets.
The Affiliated Hospital of Inner Mongolia Medical University, Hohhot
First Affiliated Hospital of Inner Mongolia technological University, Baotou
Beijing Anzhen Hospital,Capital Medical University, Beijing
Beijing Hospital, Beijing
Peking University First Hospital, Beijing
Beijing Tongzhou District Luhe Hospital, Beijing, P.R.China, Beijing
The First Affiliated Hospital of Dalian Medical University, Dalian
Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian
The Second Hospital of Dalian Medical University, Dalian
Jilin Province People's Hospital, Changchun
The First Hospital of Jilin University, Changchun
Yanbian University Hospital, Yanji
Tong Ren Hospital Shanghai Jiaotong University School of Medicine, Shanghai
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai
The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen
Nanjing Medical University Affiliated 2nd Hospital, Nanjing
The First People's Hospital of Changzhou, Changzhou
Northern Jiangsu People's Hospital, Yangzhou
Anhui Provincial Hospital, Hefei
The Affiliated Hospital of Qingdao University, Qingdao
Jiangxi Pingxiang People's Hospital, Pingxiang
The Third Xiangya Hospital of Central South University, Changsha
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan
Guangzhou First People's Hospital, Guangzhou
Zhujiang Hospital of Southern Medical University, Guangzhou
Shenzhen People's Hospital, Shenzhen
Foshan First People's Hospital, Foshan
Hainan General Hospital, Haikou
The First People's Hospital of Yunnan Province, Kunming
Jieyang People's Hospital, Jieyang
Eisai Co., Ltd.
INDUSTRY